Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Transferring lessons learnt from treating ALL to AML

Saar Gill • 5 Oct 2017
ESH 2017
Acute Myeloid Leukemia Leukemia CAR-T

Reflecting upon past research is key to the development of new treatments. In this interview at the International Conference of Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Hematology (ESH), Saar Gill, MD, PhD from the University of Pennsylvania, Philadelphia, PA, reflects upon the lessons learnt from treating acute lymphoblastic leukemia and how these lessons can be applied when tackling acute myeloid leukemia using CAR T-cells or bispecific antibodies.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Saar Gill

Immunotherapeutics in AML
Immunotherapeutics in AML
Amer Zeidan et al. • 29 Sep 2022
Translational insights into T-cell engagers and CAR T-cell therapy: targets, the microbiome, & more
11:47
Translational insights into T-cell engagers and CAR T-cell therapy: targets, the microbiome, & more
Ciara Freeman et al. • 12 Apr 2025
An update on CAR-T in CLL
An update on CAR-T in CLL
Saar Gill et al. • 29 May 2024
Exploring the potential of CAR-T therapy in CLL
16:12
Exploring the potential of CAR-T therapy in CLL
John Gribben et al. • 30 Apr 2022

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals